Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines-Reference-Cited by-同舟云学术

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines

Published:2018-01-24 Issue:1 Volume:13 Page:e0191766
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Maleki Vareki Saman,Salim Kowthar Y.,Danter Wayne R.,Koropatnick James

Funder

Critical Outcome Technologies, Inc. (COTI)Critical Outcome Technologies, Inc. (COTI, now known as Cotinga Pharmaceuticals, Inc.)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Combine and conquer: challenges for targeted therapy combinations in early phase trials;JS Lopez;Nat Rev Clin Oncol,2016

2. New and emerging targeted treatments in advanced non-small-cell lung cancer;FR Hirsch;Lancet,2016

3. Better Together: Targeted Combination Therapies in Breast Cancer;E Zanardi;Semin Oncol,2015

4. Targeting cell death signalling in cancer: minimising 'Collateral damage';JL Fox;Br J Cancer,2016

5. Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents;T Fojo;Ann Oncol,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer;European Journal of Medicinal Chemistry;2024-04

2. Advancing Drug Development with aiHumanoid Simulations: A Virtual Phase 1 Comparative Study of Standard Chemotherapy versus Standard Chemotherapy plus COTI-2 for Pancreatic Adenocarcinoma;2023-09-10

3. Human serum albumin as a copper source for anticancer thiosemicarbazones;Metallomics;2023-07-28

4. Molecular and biological factors in the prognosis of head and neck squamous cell cancer;Molecular Biology Reports;2023-07-26

5. Application of Cyclodextrin for Cancer Immunotherapy;Molecules;2023-07-24